These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4374157)

  • 1. Sleep amphetamine effects in MBDS and normal subjects.
    Feinberg I; Hibi S; Braun M; Cavness C; Westerman G; Small A
    Arch Gen Psychiatry; 1974 Nov; 31(5):723-31. PubMed ID: 4374157
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dextroamphetamine sulfate on EEG sleep patterns of hyperactive children.
    Small A; Hibi S; Feinberg I
    Arch Gen Psychiatry; 1971 Oct; 25(4):369-80. PubMed ID: 4330086
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of nocturnally administered stimulant medication on EEG sleep and behavior in hyperactive children.
    Chatoor I; Wells KC; Conners CK; Seidel WT; Shaw D
    J Am Acad Child Psychiatry; 1983 Jul; 22(4):337-42. PubMed ID: 6875127
    [No Abstract]   [Full Text] [Related]  

  • 4. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys.
    Schmidt ME; Kruesi MJ; Elia J; Borcherding BG; Elin RJ; Hosseini JM; McFarlin KE; Hamburger S
    Psychiatry Res; 1994 Nov; 54(2):199-210. PubMed ID: 7761553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder.
    Zametkin AJ; Brown GL; Karoum F; Rapoport JL; Langer DH; Chuang LW; Wyatt RJ
    Am J Psychiatry; 1984 Sep; 141(9):1055-8. PubMed ID: 6380319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing stimulant medication for attention-deficit/hyperactivity disorder.
    Wender EH
    Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 12. Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity.
    Greenhill L; Puig-Antich J; Goetz R; Hanlon C; Davies M
    Sleep; 1983; 6(2):91-101. PubMed ID: 6878986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine in the treatment of minimal brain dysfunction in children.
    Gross MD
    Psychosomatics; 1973; 14(5):283-5. PubMed ID: 4794958
    [No Abstract]   [Full Text] [Related]  

  • 14. Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs.
    Arnold LE; Kirilcuk V; Corson SA; Corson EO
    Am J Psychiatry; 1973 Feb; 130(2):165-70. PubMed ID: 4568123
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to Brasić (2007): psychomotor study of children with ADHD.
    Pedersen SJ
    Percept Mot Skills; 2008 Jun; 106(3):891-2. PubMed ID: 18712212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
    Arnold LE; Christopher J; Huestis R; Smeltzer DJ
    Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
    Kollins SH; Shapiro SK; Newland MC; Abramowitz A
    Exp Clin Psychopharmacol; 1998 Nov; 6(4):375-389. PubMed ID: 9861552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: a double-blind comparison.
    Huestis RD; Arnold LE; Smeltzer DJ
    Am J Psychiatry; 1975 Aug; 132(8):868-70. PubMed ID: 1096645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.